These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16944044)

  • 1. Two years of growth hormone replacement therapy in a group of patients with Sheehan's syndrome.
    Soares DV; Spina LD; de Lima Oliveira Brasil RR; Lobo PM; Salles E; Coeli CM; Conceição FL; Vaisman M
    Pituitary; 2006; 9(2):127-35. PubMed ID: 16944044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carotid artery intima-media thickness and lipid profile in adults with growth hormone deficiency after long-term growth hormone replacement.
    Soares DV; Spina LD; de Lima Oliveira Brasil RR; da Silva EM; Lobo PM; Salles E; Coeli CM; Conceição FL; Vaisman M
    Metabolism; 2005 Mar; 54(3):321-9. PubMed ID: 15736109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
    Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
    Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
    Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
    Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency.
    Colao A; Di Somma C; Filippella M; Rota F; Pivonello R; Orio F; Vitale G; Lombardi G
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):360-6. PubMed ID: 15355453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose metabolism and visceral fat in GH deficient adults: two years of GH-replacement.
    Spina LD; Soares DV; Brasil RR; Lobo PM; Lúcia Conceição F; Vaisman M
    Pituitary; 2004; 7(3):123-129. PubMed ID: 16328562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database.
    Kelestimur F; Jonsson P; Molvalilar S; Gomez JM; Auernhammer CJ; Colak R; Koltowska-Häggström M; Goth MI
    Eur J Endocrinol; 2005 Apr; 152(4):581-7. PubMed ID: 15817914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency.
    Colao A; Di Somma C; Rota F; Pivonello R; Savanelli MC; Spiezia S; Lombardi G
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2056-62. PubMed ID: 15671089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults.
    Chrisoulidou A; Beshyah SA; Rutherford O; Spinks TJ; Mayet J; Kyd P; Anyaoku V; Haida A; Ariff B; Murphy M; Thomas E; Robinson S; Foale R; Johnston DG
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3762-9. PubMed ID: 11061536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
    Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
    Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency.
    Colao A; Di Somma C; Spiezia S; Savastano S; Rota F; Savanelli MC; Lombardi G
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3416-24. PubMed ID: 18593773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency.
    Gómez JM; Sahún M; Vila R; Domènech P; Catalina P; Soler J; Badimón L
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):632-9. PubMed ID: 16712664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance, metabolic syndrome and chronic low grade inflammation in Sheehan's syndrome on standard replacement therapy: a case control study.
    Bhat MA; Laway BA; Shah ZA; Wani AI; Mubarik I
    Pituitary; 2015 Jun; 18(3):312-8. PubMed ID: 24879499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.
    Monson JP; Abs R; Bengtsson BA; Bennmarker H; Feldt-Rasmussen U; Hernberg-Stâhl E; Thorén M; Westberg B; Wilton P; Wüster C
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):281-9. PubMed ID: 10971444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy.
    O'Neal DN; Hew FL; Best JD; Alford F
    Growth Horm IGF Res; 1999 Jun; 9(3):165-73. PubMed ID: 10502452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose metabolism and visceral fat in GH deficient adults: 1 year of GH replacement.
    Spina LD; Soares DV; Brasil RR; da Silva EM; Lobo PM; Conceição FL; Vaisman M
    Growth Horm IGF Res; 2004 Feb; 14(1):45-51. PubMed ID: 14700554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehan's syndrome and effects of GH replacement therapy.
    Golgeli A; Tanriverdi F; Suer C; Gokce C; Ozesmi C; Bayram F; Kelestimur F
    Eur J Endocrinol; 2004 Feb; 150(2):153-9. PubMed ID: 14763913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men.
    Wallenfeldt K; Bokemark L; Wikstrand J; Hulthe J; Fagerberg B
    Stroke; 2004 Oct; 35(10):2248-52. PubMed ID: 15345795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.
    Weaver JU; Monson JP; Noonan K; John WG; Edwards A; Evans KA; Cunningham J
    J Clin Endocrinol Metab; 1995 Jan; 80(1):153-9. PubMed ID: 7829604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults.
    Oliveira JL; Aguiar-Oliveira MH; D'Oliveira A; Pereira RM; Oliveira CR; Farias CT; Barreto-Filho JA; Anjos-Andrade FD; Marques-Santos C; Nascimento-Junior AC; Alves EO; Oliveira FT; Campos VC; Ximenes R; Blackford A; Parmigiani G; Salvatori R
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4664-70. PubMed ID: 17911170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.